Marathon Petroleum (MPC) Jumps After Destroying Low Earnings Expectations

Michael Teague |

It was the downstream oil and gas industry’s turn to report earnings for the recently-ended fourth quarter ahead of the opening bell on Wednesday. While the biggest publicly traded firms like Phillips 66 (PSX) , Hess Corporation (HES) and Marathon Petroleum (MPC) were all less profitable on a year-over-year basis, all were trading higher into midday due to beating street expectations.

Marathon was far ahead of the pack, however, with shares up over 5 percent and approaching the stock’s 52-week high of $91.95 per share. The company said that during the recently-ended period, it had earned $633 million, or $2.10 per share on revenue of $24.9 billion, compared to the prior year’s Q4 during which net earnings were at $755 million, or $2.26 per share on revenue of $20.69 billion. The year-over-year decrease in net profit for the quarter was adequately made up for by the fact that earnings blew past street estimates, nearly doubling up on expectations of $1.16 per share.

For the full year 2013, profits were also better than had been anticipated, as the company posted $6.81 per share against expectations for an eps figure of about $1 lower at $5.91. Full year revenue of $100.3 billion was nearly a 22 percent gain on the previous year’s, and also ahead of estimates of $98.5 billion.

By segment, company’s refining suffered from lower margins than the previous year, which was largely attributed to greater expenses resulting from shutdowns and repairs, as well as the WTI/Brent crude spread that was narrower for most of the year as US crude production hit new highs throughout the year. The company’s midstream pipeline segment also suffered a 35 percent decline in profitability, but much of this was countered by a 27 percent increase in sales volume from the refining/marketing segment. Also, the company’s retail segment beat out the prior year’s quarter by $6 million.

Heading towards the closing bell, shares for Marathon were trading on heavy volume at around $86.90 a piece.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
HES Hess Corporation 52.76 0.11 0.21 2,488,023
MPC Marathon Petroleum Corporation 44.09 1.04 2.42 4,808,886
ONCGF Oncology Venture Sweden AB 1.44 0.00 0.00 0
PSX Phillips 66 80.35 0.61 0.76 2,070,785


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…